CW October 2004Issue Number 10 October 2004 ISSN 10593802 Antibody-based Drug to Treat OsteoporosisAMG-162, a monoclonal antibody, may prevent bone resorption associated with advancing age or due to cancer spread to bone.
Go to Previous Page Go to Next Page Source & Additional Reaading Annual Meeting at the American College of Rheumatology in San Antonio, TX on October 19, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |